RITUXIMAB MAINTENANCE AFTER AUTOLOGOUS TEM CELL TRANSPLANTATION PROLONGS SURVIVAL IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: FINAL RESULTS OF THE LYMA TRIAL OF THE LYSA/GOELAMS GROUP

Affiliation auteurs!!!! Error affiliation !!!!
TitreRITUXIMAB MAINTENANCE AFTER AUTOLOGOUS TEM CELL TRANSPLANTATION PROLONGS SURVIVAL IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: FINAL RESULTS OF THE LYMA TRIAL OF THE LYSA/GOELAMS GROUP
Type de publicationJournal Article
Year of Publication2017
AuteursLe Gouill S., Thieblemont C., Oberic L., Moreau A., Nouabdallah K., Gyan E., Damaj G., Ribrag V., Feugier P., Casasnovas O., Zerazhi H., Haioun C., Tilly H., Tournilhac O., Maisonneuve H., Le Du K., Fornecker L.M, Van den Neste E., Canioni D., Salles G., T. De La Chapelle L, Bene M-C, Gressin R., Hermine O.
JournalHAEMATOLOGICA
Volume102
Pagination4
Date PublishedJUN 26
Type of ArticleMeeting Abstract
ISSN0390-6078